Preliminary research show conolidine may possibly inhibit particular ion channels, reducing neuronal excitability and limiting discomfort alerts. This system is especially relevant in neuropathic discomfort, where irregular signaling will cause persistent irritation. In addition, conolidine seems to affect G protein-coupled receptor (GPCR) pathways

May support decrease nerve agony and distress: Apart from relieving joint ache, the complement has also been located to help with nerve agony relief and ease the discomfort that comes with it.The development of this kind of metabolites is often a recognized hazard Consider drug toxicity, as found with other compounds metabolized by cytochrome P450